Kristen Dahlgren
Showing 1–2 of 2 transcripts.
- Milken Institute6h 47m
Celebrating America's Patient Advocates: Advancing the Next Era of Innovation and Access
David Trulio, Kristen Schneemann, Dr. Francis Collins, Brian Wallach, Sandra Abravea, Margaret Anderson, Debbie, Erin, Ellen, Peter, Aaron, Ramy Pierini, Eric Racine, Dr. Wayne Frederick, Annie Kennedy, Adrienne Shapiro, Sean Martin, Leah Howard, Jean Wright, Dominica Kovacs, Roy Swartz, Dr. Uche Blackstock, Kristen Dahlgren, Darius Tahir, Donna Cryer, Angie Davis, Natasha Fitter, Randy Ruta, Bill Lawrence, Michael Hund, Dr. Roland Illing, Emily Taylor, Sarah, Isaiah, Christine
The Milken Institute convened patient advocates, researchers, and industry leaders to mark its 250th anniversary by formalizing a transition from token consultation to active partnership in healthcare innovation. The gathering showcased significant milestones such as the $1.6 billion ALS funding mobilization and the Crohn's & Colitis Foundation's use of consented patient data to accelerate research timelines, while simultaneously drafting a Declaration for Patient-Driven Innovation to secure structural funding and policy support. Participants concluded by identifying critical barriers in rare disease data and regulatory access, committing to a unified strategy that leverages AI and coalition-building to transform patients from subjects into primary drivers of care delivery and research agendas.
- Milken Institute6 min
LeadersLink Kristen Dahlgren
Founded by journalist and breast cancer survivor Kristin Dahlgren, the Cancer Vaccine Coalition accelerates the development of immune-activating cancer vaccines by rapidly scaling from a startup into a global network coordinating its first summit with the AACR and HSBC Bank. Despite early operational hurdles in defining the therapeutic sector, the organization secured its first major donation and clinical trial funding while leveraging the Leaders Link program to access high-level mentorship and strategic partnerships. With a documentary in production to drive public awareness, the coalition aims to shorten the five-to-ten-year timeline for patient access to less toxic, faster-acting cancer treatments.